✦ LIBER ✦

Low transplant-related mortality after second allogeneic peripheral blood stem cell transplant with reduced-intensity conditioning in adult patients who have failed a prior autologous transplant

✍ Scribed by Martino, R; Caballero, M D; de la Serna, J; Díez-Martín, J L; Urbano-Ispízua, A; Tomás, J F; Odriozola, J; León, A; Canals, C; San Miguel, J

Book ID: 110013339
Publisher: Nature Publishing Group
Year: 2002
Tongue: English
Weight: 97 KB
Volume: 30
Category: Article
ISSN: 0007-1188
DOI: 10.1038/sj.bmt.1703606

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Elderly age and prior autologous transpl

Elderly age and prior autologous transplantation have a deleterious effect on survival following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: results from the Spanish multicenter prospective trial

✍ Gómez-Núñez, M; Martino, R; Caballero, M D; Pérez-Simón, J A; Canals, C; Mateos, 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 139 KB

Treosulfan-based conditioning regimen in

Treosulfan-based conditioning regimen in a second matched unrelated peripheral blood stem cell transplantation for a pediatric patient with CGD and invasive aspergillosis, who experienced initial graft failure after RIC

✍ Maja Agnieszka Klaudel-Dreszler; Krzysztof Kalwak; Magdalena Kurenko-Deptuch; Be 📂 Article 📅 2009 🏛 Carden Jennings Publishing 🌐 English ⚖ 170 KB

High-dose therapy and autologous periphe

High-dose therapy and autologous peripheral blood stem cells transplantation followed by a very low reduced intensity regimen with fludarabine + cyclophosphamide and allograft improve complete remission rate in de novo multiple myeloma patients

✍ Massimo Martino; Giuseppe Console; Giuseppe Irrera; Giulia Praticò; Caterina Ste 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 240 KB 👁 2 views

## Abstract The recent development of reduced intensity conditioning and allotransplantation (RICT) has opened a new way to assure engraftment of donor cells while reducing early transplant‐related mortality. We evaluated the combination of high‐dose therapy and autologous peripheral blood stem cel